Expansion Potential Fivos has a mid-sized yet growing footprint with 51-200 employees and a revenue range of 25M-50M, signaling a scalable platform ready to handle larger registry and data services, making it a prime target for upsell on advanced data solutions, expanded reporting, and broader device manufacturer partnerships.

Commercial Partnerships Recent partnerships and client wins, including a new agreement with Carta Healthcare to enhance clinical data abstraction for national vascular registries, indicate a strong appetite for hybrid intelligence and outsourced data capabilities, presenting opportunities to cross-sell registry development, data services, and analytics offerings to related registries and societies.

Regulatory and Registry Focus Fivos specializes in real world data for medical registries and device manufacturers, with existing collaborations to support vascular quality initiatives; this aligns well with health tech buyers seeking compliant data capture, advanced reporting, and registry management across new clinical domains.

Technology Stack Leverage Utilizing Power BI, Oracle Database, Salesforce, NetSuite, DocuSign and Smartsheet suggests readiness for integrated analytics, CRM, ERP, and automated workflows; sales opportunities exist in offering end-to-end data pipelines, secure documentation, and scalable analytics for growing registries and manufacturers.

Strategic Growth Indicators Historical partnerships such as Cedaron Medical and ongoing regulatory-focused services position Fivos as a credible partner for broader SVS VQI and other vascular registries, opening avenues to expand contract value through multi-registry deployments, managed services, and extended reporting capabilities.